Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by AlloVir AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer May 16, 2023 From AlloVir Via Business Wire Tickers ALVR AlloVir Reports First Quarter 2023 Financial Results May 04, 2023 From AlloVir Via Business Wire Tickers ALVR AlloVir Appoints Derek Adams, Ph.D., to Board of Directors February 23, 2023 From AlloVir Via Business Wire Tickers ALVR AlloVir Announces Positive Final Results in Phase 2 Posoleucel Multi-Virus Prevention Study In Oral Presentation at the 64th ASH Annual Meeting and Exposition December 10, 2022 From AlloVir Via Business Wire Tickers ALVR AlloVir to Participate in the Piper Sandler 34th Annual Healthcare Conference November 15, 2022 From AlloVir Via Business Wire Tickers ALVR FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for Prevention of Multiple Life-Threatening Infections from Six Viruses in Allogeneic Hematopoietic Cell Transplant Patients April 20, 2022 From AlloVir Via Business Wire Tickers ALVR AlloVir Appoints Shawn Tomasello to Its Board of Directors March 31, 2022 From AlloVir Via Business Wire Tickers ALVR AlloVir Initiates Global Phase 3 Registrational Study of Posoleucel for Prevention of Life-Threatening Viral Infections from Six Common Viruses in High-Risk, Allogeneic Hematopoietic Cell Transplant Patients March 22, 2022 From AlloVir Via Business Wire Tickers ALVR AlloVir to Participate in the 11th Annual SVB Leerink Global Healthcare Conference February 11, 2022 From AlloVir Via Business Wire Tickers ALVR AlloVir Reports Full-Year 2021 Financial Results and 2022 Outlook February 10, 2022 From AlloVir Via Business Wire Tickers ALVR FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for the Treatment of Adenovirus (AdV) Infections in Adults and Children Post-Allogeneic Stem Cell Transplantation January 05, 2022 From AlloVir Via Business Wire Tickers ALVR AlloVir to Present at the 40th Annual J.P. Morgan Healthcare Conference January 03, 2022 From AlloVir Via Business Wire Tickers ALVR AlloVir Announces Departure of Chief Medical Officer Augustin Melian December 16, 2021 From AlloVir Via Business Wire Tickers ALVR AlloVir Announces Positive Preliminary Data from the Ongoing Phase 2 Posoleucel Multi-Virus Prevention Study at the 63rd American Society of Hematology Annual Meeting December 11, 2021 From AlloVir Via Business Wire Tickers ALVR AlloVir to Host Virtual Investor Event December 02, 2021 From AlloVir Via Business Wire AlloVir Reports Third Quarter 2021 Financial Results November 05, 2021 From AlloVir Via Business Wire Tickers ALVR AlloVir Reports Second Quarter 2021 Financial Results August 06, 2021 From AlloVir Via Business Wire Tickers ALVR AlloVir Reports First Quarter 2021 Financial Results May 06, 2021 From AlloVir Via Business Wire Tickers ALVR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.